Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/1991
09/05/1991WO1991012816A1 Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens
09/05/1991WO1991012812A1 Inhibitors of catalytic antibodies
09/05/1991WO1991011525A3 Vaccines
09/05/1991WO1991011201A3 Compounds
09/05/1991WO1991010722A3 Chimeric immunoglobulin for cd4 receptors
09/05/1991WO1991006866A3 Urinary tumor associated antigen, antigenic subunits uses and methods of detection
09/05/1991DE4005630A1 Monoclonal antibodies against tumour-associated antigens - specifically MAB BW SCLC-1 and MAB BW SCLC-2, used in immune therapy and treatment and diagnosis of tumours
09/04/1991EP0445078A1 New use of a monoclonal antibody
09/04/1991EP0444560A1 Antibody specific for the tumor necrosis factor receptor
09/04/1991EP0444181A1 C-erbb-2 external domain: gp75
09/04/1991CN1054192A Process for preparing inducing interferon of human body
09/04/1991CA2037446A1 Human monoclonal antibodies against rabies viruses, the production and the use thereof
09/03/1991WO1991013166A1 Antibody constructs with enhanced binding affinity
09/03/1991WO1991013085A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis
09/03/1991WO1991012819A1 Improved immunogenic compositions
09/03/1991US5045456 Process for removing bacterial endotoxin from gram-negative polysaccharides
09/03/1991US5045320 Large multivalent immunogen
09/03/1991US5045313 Toxoplasma gondii mutant
09/03/1991US5045203 Separation of protein antigens of Bordetella bacteria by affinity chromatography
09/03/1991CA2077352A1 Immunogenic compositions
09/03/1991CA2077348A1 Antibody constructs with enhanced binding affinity
09/03/1991CA2077345A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis
09/03/1991CA2077340A1 Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens
09/03/1991CA2025695A1 Chimeric antibody against drug-resistant cancers and process for production thereof
09/03/1991CA1288342C Method of antibodies separation from erythrocytes and separation solventsfor its use
08/1991
08/29/1991WO1991013359A1 A method and compositions to screen compounds for enhancement of the cholinergic, dopaminergic and serotonergic function
08/29/1991DE4006269A1 Antibody which binds to tumour necrosis factor receptors
08/29/1991CA2076665A1 Method and compositions to screen compounds for enhancement of the cholinergic, dopaminergic and serotonergic function
08/29/1991CA2037199A1 Inhibitors of catalytic antibodies
08/28/1991WO1991013096A1 Method for detection of borrelia burgdorferi, purified antigen thereof and antibody capable of binding therewith
08/28/1991EP0443599A2 Monoclonal antibodies specific for tumor-associated antigens, method for their preparation and their use
08/28/1991EP0443518A2 Pharmaceutical containing episialo complex carbohydrate
08/28/1991EP0443511A2 Monoclonal antibodies specific for myosin in the brain
08/28/1991EP0443335A1 Recombinant pox virus plasmid containing a multi-functional DNA cassette
08/28/1991EP0442926A1 Polypeptides
08/28/1991EP0164403B1 Feline leukemia virus vaccine
08/28/1991EP0116571B1 Method for making gamma globulin-containing compositions
08/28/1991CA2076855A1 Method for detection of borrelia burgdorferi, purified antigen thereof and antibody capable of binding therewith
08/27/1991US5043422 Polypeptide; prevention, therapy aids
08/27/1991US5043158 Immunogenic compositions containing ordered carriers
08/27/1991US5043157 Feline infectious peritonitis vaccine and method of preparation
08/27/1991CA1288197C Metal ion labeling of carrier molecules
08/27/1991CA1288046C Process for the separation of antifactor viii:c antibodies, more particularly usable for the purification of the blood plasma of a type a hemophiliac
08/23/1991WO1991013161A1 Antigenic proteins of plasmodium
08/23/1991CA2076035A1 Antigenic proteins of plasmodium
08/22/1991WO1991012529A1 E. HISTOLYTICA Gal/GalNAc LECTIN
08/22/1991WO1991012325A1 Htlv envelope antigenic segment
08/22/1991WO1991012318A1 Recombinant poxvirus internal cores
08/22/1991WO1991012269A1 Immunologically active peptides or polypeptides from the parvovirus b19
08/21/1991EP0442394A2 Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
08/21/1991EP0441897A1 Parvovirus capsids
08/21/1991EP0161306B1 Method for detecting immune complexes in serum
08/20/1991US5041536 Polypeptides; glycoprotein gx; kits for detecting infected animals
08/20/1991US5041533 Hinge peptide, a process for its manufacture, and its use for the manufacture of synthetic immunogens
08/20/1991US5041381 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
08/20/1991US5041379 Gene expression under control of heliothis promoters
08/20/1991US5041370 Transformation with recombinant DNA sequence for glycoprotein gX; veterinary medicine
08/20/1991CA2036365A1 Pharmaceutical containing episialo complex carbohydrate
08/20/1991CA1287811C Antihuman pulmonary adenocarcinoma monoclonal antibody
08/15/1991WO1991012332A1 Monoclonal antibodies for recognizing a peptide linked to a major histocompatibility antigen
08/15/1991CA2051651A1 Monoclonal antibodies recognizing a peptide associated with a major histocompatibility antigen
08/15/1991CA2033757A1 Recombinant poxvirus internal cores
08/14/1991EP0441395A2 Human monoclonal antibody and pharmaceutical composition containing the same for the treatment of pseudomonas infections
08/14/1991EP0441071A1 Transformed shigella
08/14/1991DE4003826A1 Immunologisch aktive peptide des parvovirus b19 Immunologically active peptide of parvovirus b19
08/14/1991CN1053814A 疟疾疫苗 Malaria Vaccine
08/14/1991CN1053747A Preparation technology of vaccine immunity adjuvant for hepatitis b gene engineering
08/13/1991WO1991012020A1 Novel vaccine and method therefor
08/13/1991US5039610 Alcoholic precipitation
08/13/1991US5039608 Process for preparing antigen fractions designed for the detection of antibodies indicative of a cardiovascular risk condition and their use in the diagnosis of a cardiovascular risk condition
08/13/1991US5039521 Immune cell proliferation inhibitors
08/13/1991US5039483 Antiprotozoan method
08/13/1991CA1287579C Combined vaccine
08/13/1991CA1287578C Anti-human ovarian cancer immunotoxins and methods of use thereof
08/09/1991CA2035848A1 Human monoclonal antibody and pharmaceutical composition containing the same for the treatment of pseudomonas infectins
08/08/1991WO1991011719A1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
08/08/1991WO1991011525A2 Vaccines
08/08/1991WO1991011516A1 Polypeptides and dna encoding same, associated with human malaria parasites
08/08/1991WO1991011465A1 Vaccines against cancer and infectious diseases
08/08/1991WO1991011456A1 EXTRACELLULAR SEGMENTS OF HUMAN ε IMMUNOGLOBULIN ANCHORING PEPTIDES AND ANTIBODIES SPECIFIC THEREFOR
08/08/1991WO1991011201A2 Compounds
08/08/1991WO1991009958A3 Method of delivering molecules into eukaryotic cells
08/08/1991WO1991008771A3 Method for intensive, in vitro culture of babesia divergens strains, method for preparing exoantigens and vaccines containing these antigens
08/08/1991DE4002981A1 Epididymis-specific DNA sequences
08/08/1991CA2351642A1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
08/08/1991CA2035576A1 Conformational epitopes of human immunodeficiency virus envelope glycoprotein gp120 hiv-1
08/07/1991WO1991012321A1 Transformed shigella
08/07/1991WO1991012022A1 Immune complexes
08/07/1991EP0440483A2 Process for purifying immune serum globulins
08/07/1991EP0440351A2 Recombinant human anti-CD18 antibodies
08/07/1991EP0440321A2 Epididymis specific DNA sequences and their use
08/07/1991EP0440289A1 Liposome-containing intranasal vaccine formulation
08/07/1991EP0440219A1 cDNA corresponding to the genome of negative-strand RNA viruses, and process for the production of infectious negative-strand RNA viruses
08/07/1991EP0439954A2 Hybrid molecules having translocation region and cell-binding region
08/07/1991EP0439797A1 Antibodies specifically recognizing somatotropin binding protein
08/07/1991EP0439601A1 Composition containing a b epitope of the envelope glycoprotein of a retrovirus and a t epitope of a distinct protein from this virus.
08/07/1991EP0439545A1 Methods of and compositions for diagnosing, monitoring and treating the early stages of osteosarthritis
08/07/1991EP0439542A1 Filamentous hemagglutinin of b. pertussis
08/07/1991CN1053642A 传染性支气管炎病毒疫苗 Infectious bronchitis virus vaccine
08/07/1991CA2073964A1 Immune complexes
1 ... 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 ... 1823